PERSPECTA

News from every angle

← Back to headlines

Ypsomed CEO Simon Michel Faces Challenges in US Weight-Loss Drug Market Expansion

Swiss FDP National Councillor and Ypsomed CEO Simon Michel is under pressure to accelerate his company's expansion in the US market for weight-loss injections, where it has fallen behind its main competitor.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

nzzGerman89d ago

Wegen Abnehmspritzen: FDP-Nationalrat Simon Michel muss auch als Chef von Ypsomed für Tempo sorgen

In der Europapolitik ist Simon Michel stark gefordert. Auch seine Firma Ypsomed verlangt ihm volle Aufmerksamkeit ab. Bei der Expansion in den USA ist das Burgdorfer Medizintechnikunternehmen in Rückstand zum Hauptkonkurrenten geraten.

Read full article →

Related Stories

Common Beverages Often Contain More Sugar Than a Glazed Donut

40m ago

Blood Test for Cancer Recurrence Could Be Implemented in Years

1h ago

Mother Tattoos Keyboard on Arm to Communicate with Autistic Son

1h ago

Sri Lankan Doctors Remove Record-Breaking 3.1kg Bladder Stone

2h ago